NYU Langone Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).
NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.
NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.
Top-decile sponsor footprint
NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,164 total, page 13 of 24
Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders
NCT03606668
Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder
NCT03544112
Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination
NCT03601741
Reducing Hemarthrosis in ACL Reconstruction With BTB Autograft by the Administration of Intravenous TXA
NCT03631355
Adherence to and Beliefs on Recommendations for Behavioral Treatment for Migraine
NCT03799211
Association Between Inpatient Steps Per Day and Patient Functional Status/Disposition
NCT03595605
A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret
NCT03523871
Stress Management to Support Women's Health
NCT03223545
Neurobiology of Sensory Phenomena in Obsessive-Compulsive Disorder
NCT03451409
A Phase Ib Study Evaluating the Safety and Tolerability of Vitamin C in Patients With Intermediate or High Risk Myelodysplastic Syndrome With TET2 Mutations
NCT03433781
A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma
NCT03565406
Behavioral Management of Phosphorus in Hemodialysis Patients
NCT02940743
A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)
NCT03499314
Multimodal Analgesia With Acetaminophen vs. Narcotics Alone After Hip Arthroscopy
NCT03510910
BRInging the Diabetes Prevention Program to GEriatric Populations - PILOT
NCT03524404
Emergency Medicine Palliative Care Access
NCT03325985
Orexin and Tau Pathology in Cognitively Normal Elderly
NCT03053908
Improving Sleep Using Mentored Behavioral and Environmental Restructuring
NCT03327324
Directional Versus Orbital Atherectomy Plaque Modification and Luminal Area Assessment of the Femoro-popliteal Artery Via Intravascular Ultrasound
NCT03495453
Resident Observed Burnout After Daily Supplementation With Coffee
NCT03355144
Gravity Flow Technique to Validate Proper Location of Epidural Needle Tip on Obese Parturients
NCT03437889
Neurophysiological and Functional Mechanisms of Motor Control and Learning
NCT03190590
Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
NCT03183778
Program of Intensive Support in Emergency Departments for Care Partners of Cognitively Impaired Patients
NCT03325608
Stress Reduction Intervention for Women With Ischemic Heart Disease
NCT02893579
Burnout and Approach to Bereavement Initiatives in a Medical Intensive Care Unit (ICU)
NCT03398460
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements (CDEs) Into the Electronic Health Record (EHR) in Large Primary Care Settings ("CDE-EHR-PC" Study), Phase 3
NCT02963948
Using Rapid Cycle Trials to Increase Patient Engagement in the Community Health Worker Program in the Emergency Department
NCT03455465
Increasing Patient Engagement in the Annual Well Visits Program
NCT03462394
Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.
NCT03435484
Nivolumab, Ipilimumab, and Short-course Radiotherapy in Adults With Newly Diagnosed, MGMT Unmethylated Glioblastoma
NCT03367715
Feasibility and Acceptability of a Text Messaging Intervention to Increase Smoking Cessation in Vietnam
NCT03219541
Optimal Location of Nerve Block to Minimize Perioperative Opioid Administration in ACL Surgery: Comparing True Adductor Canal to Proximal Block
NCT03401450
Function Following Thumb MP Fusion and IP Fusion
NCT03661281
Narcotics vs NSAIDs for Post-operative Analgesia in Outpatient Rhinoplasty
NCT03457116
Optimizing the Influenza Clinical Decision Support Tool
NCT03415425
An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes
NCT03409523
HCV Positive Heart Donors
NCT03382847
A Study Using Transorbital Alternating Current Stimulation for People With Glaucoma
NCT03188042
Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis
NCT03409211
A Personalized Diet Study to Reduce Glycemic Exposure
NCT03336411
Efficacy of a Gluten-free Diet in Difficult to Manage Nephrotic Syndrome: Utility of Plasma Zonulin Levels as a Predictive Biomarker
NCT03387176
Multimodal Analgesia With NSAID vs. Narcotics Alone After Shoulder Instability Surgery
NCT04018768
Retapamulin as a Decolonizing Agent for MRSA
NCT03304873
The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome
NCT03452189
The GEM (Goals for Eating and Moving) Study
NCT03006328
Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI
NCT03656250
Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty
NCT03345771
Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms
NCT03246126
Remotely-supervised Transcranial Direct Current Stimulation (tDCS) for At-home Treatment of Fatigue and Cognitive Slowing in Parkinson's Disease
NCT03189472
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 99 |
| Phase 2 | 132 |
| Phase 3 | 28 |
| Phase 4 | 95 |
Therapeutic Areas
What is open in the NYU Langone Health pipeline
197 recruiting of 1,164 indexed (17% open); 741 completed (64%).
Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NYU Langone Health: open-pipeline peers nationwide
Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,164 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
Related
What to do with this NYU Langone Health page
1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.
- 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.